HMGCS2 and metabolic dysfunction-associated steatohepatitis: Notably, HMGCS2 inhibition reduced ketone body concentrations, indicating that HMGCS2 knockdown attenuated cynaroside’s therapeutic effect on ketone body overproduction in NASH-T2DM C57BL/6J mice.